{"slideshow_credits": null, "snippet": "A drug being developed for weight loss has been tested in patients with Prader-Willi syndrome, a condition marked by incessant, uncontrollable hunger, and other studies are in the wings.", "abstract": "Research into Prader-Willi syndrome, once obscure and neglected disease which gives people incessant, uncontrollable hunger, may shed light on much broader health problems of overeating and obesity; one drug being developed for weight loss by Zafgen has been tested in patients and other studies are in the wings.", "section_name": "Health", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 1, "organization": ""}], "original": "By ANDREW POLLACK", "contributor": ""}, "web_url": "http://www.nytimes.com/2014/01/15/health/seeking-clues-to-obesity-in-rare-hunger-disorder.html", "lead_paragraph": "A drug being developed for weight loss has been tested in patients with Prader-Willi syndrome, a condition marked by incessant, uncontrollable hunger, and other studies are in the wings.", "headline": {"main": "Seeking Clues to Obesity in Rare Hunger Disorder", "print_headline": "Seeking Clues to Obesity in Rare Hunger Disorder"}, "_id": "52d5e10b38f0d85057b2e332", "word_count": "1247", "multimedia": [{"height": 126, "url": "images/2014/01/15/business/jp-obesity2/jp-obesity2-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2014/01/15/business/jp-obesity2/jp-obesity2-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 463, "url": "images/2014/01/15/business/jp-obesity1/jp-obesity1-articleLarge.jpg", "legacy": {"xlarge": "images/2014/01/15/business/jp-obesity1/jp-obesity1-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "463"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2014/01/15/business/jp-obesity2/jp-obesity2-thumbStandard.jpg", "legacy": {"thumbnail": "images/2014/01/15/business/jp-obesity2/jp-obesity2-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2014-01-15T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "Y", "rank": "3"}, {"value": "Obesity", "name": "subject", "is_major": "Y", "rank": "1"}, {"value": "Prader-Willi Syndrome", "name": "subject", "is_major": "Y", "rank": "2"}, {"value": "Zafgen Inc", "name": "organizations", "is_major": "N", "rank": "4"}], "blog": [], "subsection_name": null, "type_of_material": "News"}